-
Pemetrexed (SKU A4390): Reliable Antifolate for Cancer Assay
2026-06-16
This article dissects common laboratory challenges in cell viability and cytotoxicity studies, demonstrating how Pemetrexed (SKU A4390) from APExBIO provides reproducible results across cancer models. Grounded in peer-reviewed evidence and protocol optimization, it offers scenario-driven guidance to help researchers confidently select and use Pemetrexed in experimental workflows.
-
Clodronate Liposomes: Precision Macrophage Depletion in Vivo
2026-06-16
Clodronate Liposomes empower researchers to selectively deplete macrophages in vivo, unlocking new experimental clarity in immune modulation and therapy resistance studies. This guide delivers advanced workflows, troubleshooting advice, and real-world protocol enhancements to maximize the impact of APExBIO’s liposome-encapsulated clodronate platform.
-
PD 173074 in Epigenetic Oncology: FGFR1 Inhibition Beyond Ta
2026-06-15
Explore how PD 173074 enables advanced research on FGFR1 signaling, epigenetic regulation, and leukemia therapy. This article reveals unique insights into assay design and the translational impact of FGFR1 inhibition.
-
Protease Inhibitor Cocktail: Precision in Protein Extraction
2026-06-15
Safeguard your protein samples with the APExBIO Protease Inhibitor Cocktail (100X in DMSO, EDTA plus), engineered for robust degradation prevention in advanced cell and molecular workflows. This guide details optimized protocols, trouble-shooting strategies, and the translational impact of recent research connecting protease inhibition to reproducible, high-integrity data in cancer biology.
-
Cell lysis buffer for WB and IP: Optimizing Protein Extracti
2026-06-14
Unlock high-yield, artifact-free protein extraction from even the most challenging tissues using APExBIO's Cell lysis buffer for WB and IP. This guide translates recent tumor microenvironment discoveries into actionable workflows, with advanced troubleshooting and best-in-class inhibitor protection for demanding immunoprecipitation or Western blotting applications.
-
DiscoveryProbe Protease Inhibitor Library: Applied Workflows
2026-06-13
Unlock high-throughput, high-content insights with the DiscoveryProbe Protease Inhibitor Library—825 pre-validated, cell-permeable inhibitors ready for apoptosis, cancer, and infectious disease research. This guide covers experimental integration, workflow optimization, and troubleshooting strategies, setting new reproducibility standards for protease inhibition studies.
-
Cy5 Maleimide for Site-Specific Protein Labeling and Imaging
2026-06-12
Cy5 maleimide (non-sulfonated) delivers robust, site-specific fluorescent labeling of cysteine-containing proteins, powering sensitive imaging in complex biological systems. Its covalent thiol reactivity and high-performance spectral properties enable precise tracking and quantification—critical for dissecting molecular partitioning in condensate biology and neuroscience.
-
PPP2R2A Loss Sensitizes HGSOC to Chk1 Inhibition via Replica
2026-06-12
This study demonstrates that low PPP2R2A expression in high-grade serous ovarian cancer (HGSOC) heightens sensitivity to Chk1 inhibition by amplifying replication stress, especially in PARP inhibitor-resistant cells. The findings identify PPP2R2A as a promising biomarker for stratifying patients who may benefit from Chk1 inhibitor-based therapies, with implications for overcoming chemoresistance in aggressive ovarian cancer.
-
Direct Mouse Genotyping Kit: Streamlined PCR for GEMMs
2026-06-11
The Direct Mouse Genotyping Kit accelerates high-throughput genotyping by eliminating DNA purification, enabling direct PCR from mouse tissues—ideal for complex genetically engineered models. Learn how optimized buffer systems and dye-included PCR master mix support robust, reproducible workflows for translational oncology and beyond.
-
Nicotinamide Adenine Dinucleotide (NAD+): Experimental Power
2026-06-11
Nicotinamide Adenine Dinucleotide (NAD+) is redefining experimental strategies for researchers investigating metabolic signaling, autophagy, and DNA repair. Learn how APExBIO’s high-purity NAD+ empowers robust workflows, troubleshooting, and next-generation assay design in stress adaptation and translational biochemistry.
-
Oral Dextran Microgels with Trilaurin Lipid Nanoparticles fo
2026-06-10
This study introduces a dual-targeted system using dextran microgels loaded with trilaurin-based lipid nanoparticles (LNPs) for local oral delivery of cisplatin and SPIONs to colon cancer. The approach enhances tumor targeting, cellular uptake, and combined chemo-magnetothermal efficacy, highlighting new directions for nanoparticle-mediated oral therapeutics.
-
Npt1-Mediated Renal Secretion Mechanism for Faropenem Sodium
2026-06-10
The referenced study elucidates the molecular mechanism by which the inorganic phosphate transporter Npt1 mediates renal tubular secretion of faropenem sodium, a penem antibiotic. This mechanistic insight clarifies how specific transporter selectivity influences antibiotic pharmacokinetics and supports translational research in antimicrobial resistance.
-
Resveratrol as a SIRT1 Activator: Optimizing Applied Neuropr
2026-06-09
Resveratrol’s precise modulation of SIRT1 unlocks new experimental possibilities for dissecting mitochondrial quality control and apoptosis inhibition in neurodegenerative models. This guide translates the latest evidence into actionable protocols, troubleshooting strategies, and advanced use-cases, empowering researchers to achieve robust, reproducible insights with APExBIO’s Resveratrol.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Workf
2026-06-09
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses the need for reliable protein degradation prevention during extraction workflows, particularly where divalent cation compatibility is critical. It should be used in workflows like Western blotting, immunoprecipitation, and kinase assays, but is not suitable where EDTA or metal chelation is required.
-
Necrostatin-1: Selective RIP1 Kinase Inhibitor for Necroptos
2026-06-08
Necrostatin-1 is a potent and selective RIP1 kinase inhibitor that enables precise modulation of necroptosis in cellular and animal models. Its efficacy in blocking TNF-α-induced necroptosis and utility in acute injury research are supported by quantitative benchmarks. APExBIO’s Nec-1 provides a reproducible standard for dissecting RIP1 kinase signaling pathways.